Next Generation Sequencing Market Overview:
The global next generation sequencing market size accounted for $6,598.62 million in 2020, and is projected to reach $35,503.66 million by 2030, registering a CAGR of 18.2% from 2021 to 2030. Next generation sequencing (NGS) is a massively parallel sequencing technology, which offers scalability, ultra-high throughput, and high speed to determine the order of nucleotides in entire genome. DNA pre-sequencing is one of the most significant steps in the overall sequencing protocol as it involves preparation of sample for the subsequent sequencing reaction. NGS is steadily being integrated into clinical laboratory analysis, testing, and diseases diagnostics in healthcare sectors, globally. NGS has been widely used in pharmacogenomics to accelerate the drug discovery process.
Growth of the global next generation sequencing market is majorly driven by increase in genome mapping programs; rise in applications of next generation sequencing; increase in healthcare expenditure; and technological advancements in sequencing platforms. For instance, in 2019, Thermo Fisher Scientific, a world leader in serving science, launched Ion Torrent Genexus System which is a next generation platform that deliver the specimen to report in just a single day. Moreover, in 2019, Agilent Technologies, Inc., an American analytical development and manufacturing company, launched Magnis NGS Prep System, a next generation sequencing library preparation system which is designed to run the complex sequencing assays in a press of a button. The genetic make-up and configuration of the fetus can be detected through NGS-oriented tests such as non-invasive prenatal testing (NIPT), and pre-implantation genetic testing (PGT). The R&D related to NGS has been escalating to new heights through greater investment in NGS technologies throughout the world. Surge in demand for genome mapping program and rise in application of NGS boosts the growth of the market.
However, lack of skilled professionals, and ethical and legal limitation associated with NGS are expected to restrict the market growth during the forecast period.
By Product Type
Consumables segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.
Next Generation Sequencing Market Segmentation
The next generation sequencing market is segmented on the basis of product, application, technology, end user, and region. By product, the market is categorized into consumables, platforms, and services. On the basis of consumables, it is further classified based on sample preparation consumables and other consumables. The sample preparation consumables are further segmented into DNA fragmentation, end repair, A-Tailing & size selection, library preparation & target enrichment, and quality control. By platforms, the market is divided into HiSeq, MiSeq, Ion Torrent, SOLiD, Pacbio Rs II & Sequel System, and other sequencing platforms. By service, it is divided into sequencing services and data management. The sequencing services are further segmented into RNA sequencing, whole exome sequencing, whole genome sequencing, targeted sequencing, chip sequencing, De novo sequencing and methyl sequencing. The data management services are further segmented into NGS Data analysis services, NGS data analysis software & workbenches, and NGS storage, management and cloud computing solutions.
On the basic of application, the next generation sequencing market is divided into diagnostics, biomarkers & cancer, reproductive health, personalized medicine, agriculture & animal research, and other applications. By technology, the market is categorized into sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, pyrosequencing, single molecule real time sequencing, and other technologies. By end user, the market is categorized into academic and research centers, pharmaceutical and biotechnology companies, hospitals and clinics, and other end users.
By Application
Biomarkers And Cancer Segment hold the dominant position and would continue to maintain the lead over the forecast period.
Region wise, the market is analyzed across North America (the U.S., Canada and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, Taiwan, and rest of Asia-Pacific), and LAMEA (Brazil, Turkey, Saudi Arabia, South Africa, and rest of LAMEA).
Segment review
Depending on product, the consumables segment dominated the market in 2020, and is expected to continue this trend throughout the forecast period, owing to development of technology in molecular genetics and surge in demand for novel pre-sequencing products and kits that execute DNA fragmentation, target enrichment, size selection, and others. However, the services segment is expected to witness considerable next generation sequencing market growth during the forecast period, due to advancement in technology based on SMRT sequencing, and increase in application of cloud computing for NGS data storage.
By Technology
Sequencing by Synthesis segements holds a dominant position in 2020 and continue to maintain lead in the forecast year
On the basis of application, the biomarker and cancer segment dominated the market in 2020, and is expected to continue this trend throughout the forecast period, due to increase in prevalence of cancer and advancement in technology in next generation sequencing. However, the personalized medicine segment is expected to witness considerable next generation sequencing market growth during the forecast period, due to surge in demand for drug treatment, advancement in R&D in healthcare sector, and rise in awareness for NGS testing in pharmaceutical and biotechnological industry.
On the basis of end user, the academic & clinical research centers segment dominated the market in 2020, and is expected to continue this trend throughout the forecast period, due to increase in application-based usage in these institutes and rise in oncology research. However, the pharmaceutical & biotechnology companies’ segment is expected to witness considerable market growth during the forecast period, due to increase in prevalence of chronic disease, and advancement in R&D in the next generation sequencing market for therapeutics, oncology, and genomics research.
By End User
Academic and Clinical Research Centers segements holds a dominant position in 2020 and continue to maintain lead in the forecast year
North America accounted for a major share in the next generation sequencing market in 2020, and is expected to maintain its dominance during the forecast period, owing to technological advancements in sequencing platforms and increase in applications of NGS in this region. However, Asia-Pacific is expected to register highest CAGR of 19.0% from 2021 to 2030, due to increase in demand for NGS along with surge in awareness about NGS.
Key players operating in the global next generation sequencing market include Agilent Technologies, Inc., BGI Group, F. Hoffmann-La Roche AG, Illumina Inc, Precigen Inc., (Intrexon Bioinformatics Germany GmbH), Pacific Biosciences of California, Inc., PerkinElmer, Inc., PierianDx Inc., Qiagen N.V., and Thermo Fisher Scientific Inc.
By Region
Asia Pacific region would exhibit the highest CAGR of 19.00% during 2021-2030
Key Benefits For Stakeholders
- The study provides an in-depth analysis of the next generation sequencing market, and the current trends and future estimations to elucidate imminent investment pockets.
- It presents a quantitative analysis of the market from 2021 to 2030 to enable stakeholders to capitalize on the prevailing next generation sequencing market opportunities.
- Extensive analysis of the market based on procedures and services assists to understand the trends in the industry.
- Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the next generation sequencing market.
Key Market Segments
By Product
- Consumables
- Sample Preparation Consumables
- DNA Fragmentation, End Repair, A-Tailing and Size Selection
- Library Preparation & Target Enrichment
- Quality Control
- Sample Preparation Consumables
- Other Consumables
- Platforms
- HiSeq
- MiSeq
- Ion Torrent
- SOLiD
- Pacbio Rs II and Sequel System
- Other Sequencing Platforms
- Services
- Sequencing Services
- RNA Sequencing
- Whole Exome Sequencing
- Whole Genome Sequencing
- Targeted Sequencing
- Chip Sequencing
- De Novo Sequencing
- Methyl Sequencing
- Data Management Services
- NGS Data Analysis Services
- NGS Data Analysis Software & Workbenches
- NGS Storage, Management and Cloud Computing Solutions
- Sequencing Services
By Application
- Diagnostics
- Biomarkers and Cancer
- Reproductive Health
- Personalized Medicine
- Agriculture and Animal Research
- Other Applications
By Technology
- Sequencing by Synthesis
- Ion Semiconductor Sequencing
- Sequencing by Ligation
- Pyrosequencing
- Single Molecule Real Time Sequencing
- Other Technologies
By End User
- Academic and Research Centers
- Pharmaceutical and Biotechnology Companies
- Hospitals and Clinics
- Other End Users
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Taiwan
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Turkey
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Agilent Technologies, Inc
- BGI Group
- F. Hoffmann-La Roche AG
- Illumina Inc
- Precigen Inc., (Intrexon Bioinformatics Germany GmbH)
- Pacific Biosciences of California, Inc
- PerkinElmer, Inc.
- PierianDx Inc.
- Qiagen N.V.
- Thermo Fisher Scientific Inc.
Next Generation Sequencing Market Report Highlights
| Aspects | Details |
 By PRODUCT |
|
 By APPLICATION |
|
 By TECHNOLOGY |
|
 By END USER |
|
 By Region |
|
 Key Market Players | PERKINELMER, INC., QIAGEN N.V., AGILENT TECHNOLOGIES, INC., F. HOFFMANN-LA ROCHE AG, ILLUMINA INC., PIERIANDX INC., PACIFIC BIOSCIENCES OF CALIFORNIA, INC., PRECIGEN INC., (INTREXON BIOINFORMATICS GERMANY GMBH), THERMO FISHER SCIENTIFIC INC., BGI GROUP |
Analyst Review
According to analyst perspective, the next generation sequencing market is expected to witness a steady growth in the future. The market has drawn the interest of the healthcare industry. Owing to increase in distinct applications and interventions such as diagnostics, biomarker discovery, personalized medicine. As a technology, NGS is better and more advanced than its predecessors, especially microarray, owing to increased affordability of comprehensive sequence-based genomic analysis. The next generation sequencing market is dominated by well-established players; hence, the market is anticipated to witness intense competition. The adoption of next generation sequencing method increased considerably, due to reduced cost of NGS and significant technological advancements in NGS, and surge in collaborations & partnerships among NGS product manufacturing companies and other organizations. In addition, the reduction in sequencing time, accuracy, and precision in the results and rise in awareness regarding NGS are the key factors anticipating the market growth in the near future.
The total market value of next generation sequence market is $6,598.62 million in 2020.
The forecast period in the report is from 2021 to 2030
The market value of next generation sequence market is 35,503.66 million.
The base year for the report is 2020.
Yes, next generation sequence market companies are profiled in the report.
The top companies that hold the market share in next generation sequence market are Agilent Technologies, Inc. PerkinElmer, Inc., Genomatix GmbH,Thermo Fisher Scientific, Inc and PierianDx.
There is no value chain analysis provided in the next generation sequence market report
The key trends in the next generation sequence market are due to rise in technological advancements, especially nanopore sequencing in NGS and rise in the need to improve diagnostic procedures and ensure quality treatment is boosting the growth of next generation sequencing market.
Loading Table Of Content...
